George D A, Volpin A, Scarponi S, Haddad F S, Romanò C L
Department of Trauma and Orthopaedics, University College London Hospitals, 235 Euston Road, London, NW1 2BU, UK.
Centre for Reconstructive Surgery and Osteoarticular Infections, Orthopaedic Research Institute Galeazzi, Milan, Italy.
BMC Musculoskelet Disord. 2016 Feb 1;17:52. doi: 10.1186/s12891-016-0901-6.
The best surgical modality for treating chronic periprosthetic shoulder infections has not been established, with a lack of randomised comparative studies. This systematic review compares the infection eradication rate and functional outcomes after single- or two-stage shoulder exchange arthroplasty, to permanent spacer implant or resection arthroplasty.
Full-text papers and those with an abstract in English published from January 2000 to June 2014, identified through international databases, such as EMBASE and PubMed, were reviewed. Those reporting the success rate of infection eradication after a single-stage exchange, two-stage exchange, resection arthroplasty or permanent spacer implant, with a minimum follow-up of 6 months and sample size of 5 patients were included.
Eight original articles reporting the results after resection arthroplasty (n = 83), 6 on single-stage exchange (n = 75), 13 on two-stage exchange (n = 142) and 8 papers on permanent spacer (n = 68) were included. The average infection eradication rate was 86.7 % at a mean follow-up of 39.8 months (SD 20.8) after resection arthroplasty, 94.7 % at 46.8 months (SD 17.6) after a single-stage exchange, 90.8 % at 37.9 months (SD 12.8) after two-stage exchange, and 95.6 % at 31.0 months (SD 9.8) following a permanent spacer implant. The difference was not statistically significant (p = 0.650). Regarding functional outcome, patients treated with single-stage exchange had statistically significant better postoperative Constant scores (mean 51, SD 13) than patients undergoing a two-stage exchange (mean 44, SD 9), resection arthroplasty (mean 32, SD 7) or a permanent spacer implant (mean 31, SD 9) (p = 0.029). However, when considering studies comparing pre- and post-operative Constant scores, the difference was not statistically significant.
This systematic review failed to demonstrate a clear difference in infection eradication and functional improvement between all four treatment modalities for established periprosthetic shoulder infection. The relatively low number of patients and the methodological limitations of the studies available point out the need for well designed multi-center trials to further assess the best treatment option of peri-prosthetic shoulder infection.
由于缺乏随机对照研究,治疗慢性人工肩关节周围感染的最佳手术方式尚未确定。本系统评价比较了一期或二期肩关节置换术、永久性间隔物植入术或关节切除成形术后的感染根除率和功能结果。
检索了2000年1月至2014年6月期间通过国际数据库(如EMBASE和PubMed)发表的全文论文以及英文摘要论文。纳入那些报告一期置换、二期置换、关节切除成形术或永久性间隔物植入术后感染根除成功率的研究,最低随访时间为6个月,样本量为5例患者。
纳入了8篇报告关节切除成形术结果的原始文章(n = 83)、6篇关于一期置换的文章(n = 75)、13篇关于二期置换的文章(n = 142)以及8篇关于永久性间隔物的文章(n = 68)。关节切除成形术后平均随访39.8个月(标准差20.8)时,平均感染根除率为86.7%;一期置换术后46.8个月(标准差17.6)时为94.7%;二期置换术后37.9个月(标准差12.8)时为90.8%;永久性间隔物植入术后31.0个月(标准差9.8)时为95.6%。差异无统计学意义(p = 0.650)。关于功能结果,一期置换治疗的患者术后Constant评分(平均51,标准差13)在统计学上显著优于二期置换(平均44,标准差9)、关节切除成形术(平均32,标准差7)或永久性间隔物植入术(平均31,标准差9)治疗的患者(p = 0.029)。然而,在考虑比较术前和术后Constant评分的研究时,差异无统计学意义。
本系统评价未能证明在已确诊的人工肩关节周围感染的所有四种治疗方式之间,感染根除和功能改善方面存在明显差异。患者数量相对较少以及现有研究的方法学局限性表明,需要设计良好的多中心试验来进一步评估人工肩关节周围感染的最佳治疗选择。